Endothelial to Mesenchymal Transition in Health and Disease

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


The endothelium is one of the largest organ systems in the body, and data continue to emerge regarding the importance of endothelial cell (EC) dysfunction in vascular aging and a range of cardiovascular diseases (CVDs). Over the last two decades and as a process intimately related to EC dysfunction, an increasing number of studies have also implicated endothelial to mesenchymal transition (EndMT) as a potentially disease-causal pathobiologic process that is involved in a multitude of differing CVDs. However, EndMT is also involved in physiologic processes (e.g., cardiac development), and transient EndMT may contribute to vascular regeneration in certain contexts. Given that EndMT involves a major alteration in the EC-specific molecular program, and that it potentially contributes to CVD pathobiology, the clinical translation opportunities are significant, but further molecular and translational research is needed to see these opportunities realized.

Original languageEnglish
Pages (from-to)245-267
Number of pages23
JournalAnnual Review of Physiology
StatePublished - 10 Feb 2023


  • EndMT
  • cardiovascular
  • endothelial
  • endothelial to mesenchymal transition


Dive into the research topics of 'Endothelial to Mesenchymal Transition in Health and Disease'. Together they form a unique fingerprint.

Cite this